Klotho Neurosciences, Inc.
KLTO
$0.1748
-$0.0069-3.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.79M | 4.05M | 1.30M | 1.15M | 631.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.79M | 4.05M | 1.30M | 1.15M | 631.30K |
| Operating Income | -5.79M | -4.05M | -1.30M | -1.15M | -631.30K |
| Income Before Tax | -6.15M | -4.21M | -1.39M | -1.21M | -707.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.15 | -4.21 | -1.39 | -1.21 | -0.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.15M | -4.21M | -1.39M | -1.21M | -707.50K |
| EBIT | -5.79M | -4.05M | -1.30M | -1.15M | -631.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.28 | -0.22 | -0.05 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.18 | -0.13 | -0.03 | -0.02 | -0.02 |
| EPS Diluted | -0.29 | -0.22 | -0.05 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.18 | -0.13 | -0.03 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 1.10B | 1.09B | 1.09B | 1.09B | 1.09B |
| Average Diluted Shares Outstanding | 1.10B | 1.09B | 1.09B | 1.09B | 1.09B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |